U.S. FDA Approves Merck Immunotherapy/chemo Combo for Lung Cancer – U.S. News & World Report
U.S. News & World Report |
U.S. FDA Approves Merck Immunotherapy/chemo Combo for Lung Cancer
U.S. News & World Report A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines. REUTERS/Jeff Zelevansky … Merck Extends Immunotherapy Lead With Lung Cancer Combination Therapy Approval Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer FDA approves Merck immunotherapy/chemo combo for lung cancer |
